Salvage treatment for oropharyngeal squamous cell carcinoma
DOI:
https://doi.org/10.34631/sporl.1071Keywords:
Squamous cell carcinoma, Oropharyngeal neoplasms, Salvage therapy, RecurrenceAbstract
Objectives: Evaluate salvage surgery efficiency for treatment of residual/recurrent oropharyngeal squamous cell carcinoma after radiotherapy or chemorradiotherapy.
Methods: Retrospective study that included patients followed at Instituto Português de Oncologia de Lisboa Francisco Gentil, between 2010 and 2021. The study included 160 patients with diagnosis of squamous cell carcinoma of oropharynx, from which 44 patients with diagnosis of residual/recurrent tumor were selected.
Results: Diagnosis of residual/recurrent disease was made in 27,5% of the population initially selected. Between the ones that had local residual/recurrent disease, 8 patients (53,3%) were submitted to surgery, with a three-year overall survival of 50,0%, and the remaining 7 patients did not have favorable surgical conditions.
Conclusions: Salvage surgery for treatment of residual/recurrent oropharyngeal squamous cell carcinoma is one of the available treatments with best survival rates. Despite the aforementioned, survival rates are limited and depend on surgical margins, so this kind of treatment should be carefully considered.
References
- Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016 Mar;91(3):386-96. doi: 10.1016/j.mayocp.2015.12.017.
- Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007 Oct 1;110(7):1429-35. doi: 10.1002/cncr.22963.
-Omura G, Saito Y, Ando M, Kobayashi K, Ebihara Y, Yamasoba T. et al. Salvage surgery for local residual or recurrent pharyngeal cancer after radiotherapy or chemoradiotherapy. Laryngoscope. 2014 Sep;124(9):2075-80. doi: 10.1002/lary.24695
-Hay A, Simo R, Hall G, Tharavai S, Oakley R, Fry A. et al. Outcomes of salvage surgery for the oropharynx and larynx: a contemporary experience in a UK Cancer Centre. Eur Arch Otorhinolaryngol. 2019 Apr;276(4):1153-1159. doi: 10.1007/s00405-019-05295-x.
-Chen AY, Schrag N, Hao Y, Stewart A, Ward E. Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope. 2007 Jan;117(1):16-21. doi: 10.1097/01.mlg.0000240182.61922.31.
-Chen AY, Zhu J, Fedewa S. Temporal trends in oropharyngeal cancer treatment and survival: 1998-2009. Laryngoscope. 2014 Jan;124(1):131-8. doi: 10.1002/lary.24296.
-Bird T, De Felice F, Michaelidou A, Thavaraj S, Jeannon JP, Lyons A. et al. Outcomes of intensity-modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma – a European single institution analysis. Clin Otolaryngol. 2017 Feb;42(1):115-122. doi: 10.1111/coa.12674.
-Zafereo ME, Hanasono MM, Rosenthal DI, Sturgis EM, Lewin JS, Roberts DB. et al. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer. 2009 Dec 15;115(24):5723-33. doi: 10.1002/cncr.24595.
- Embring A, Onjukka E, Mercke C, Lax I, Berglund A, Bornedal S. et al. Re-irradiation for head and neck cancer: cumulative dose to organs at risk and late side effects. Cancers (Basel). 2021 Jun 25;13(13):3173. doi: 10.3390/cancers13133173.
- Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope. 2000 Mar;110(3 Pt 2 Suppl 93):1-18. doi: 10.1097/00005537-200003001-00001.
- Culié D, Lisan Q, Leroy C, Modesto A, Schiappa R, Chamorey E. et al. Oropharyngeal cancer: first relapse description and prognostic factor salvage treatment according to p16 status, a GETTEC multicentric study. Eur J Cancer. 2021 Jan;143:168-177. doi: 10.1016/j.ejca.2020.10.034.
- Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Bruce JY. et al. NCCN Clinical Practice Guidelines in Oncology – Head and Neck Cancers. NCCN Guidelines. 2021; ST-4-7.
- Righini CA, Nadour K, Faure C, Rtail R, Morel N, Beneyton V. et al. Salvage surgery after radiotherapy for oropharyngeal cancer. Treatment complications and oncological results. Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Feb;129(1):11-6. doi: 10.1016/j.anorl.2011.06.002.
- Sassler AM, Esclamado RM, Wolf GT. Surgery after organ preservation therapy. Analysis of wound complications. Arch Otolaryngol Head Neck Surg. 1995 Feb;121(2):162-5. doi: 10.1001/archotol.1995.01890020024006
- Virtaniemi JA, Kumpulainen EJ, Hirvikoski PP, Johansson RT, Kosma VM. The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae. Head Neck. 2001; 23:29-33. doi: 10.1002/1097-0347(200101)23:1<29::AID-HED5>3.0.CO;2-P
- Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF. et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010 Jul 1;363(1):24-35. doi: 10.1056/NEJMoa0912217.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
